James A. Klein

The Detroit Medical Center's (DMC) record of service has provided medical excellence throughout the history of the Metropolitan Detroit area. From the founding of Children's Hospital in 1886, to the creation of the first mechanical heart at Harper Hospital 50 years ago. Their medical experts are nationally recognized and each year, hundreds of DMC doctors are included in the list of America's Best Doctors. A reputation for excellence draws patients to world-class programs in oncology, organ transplant, cardiology, women's services, neurosciences, stroke treatment, optometry, orthopedics, pediatrics and rehabilitation. They are the leading academically integrated system in metropolitan Detroit and the largest health care provider in southeast Michigan. The DMC has more than 2,000 licensed beds and 3,000 affiliated physicians. Detroit Medical Center facilities employ best practices and conduct business in an atmosphere of respect and professionalism. Their recognition of and attention to diversity in their business operations and healthcare services is unparalleled. Their volunteer efforts in health education & disease prevention represent an ongoing commitment to the health and well-being of the communities they serve. The DMC continues to meet the health care needs of a growing community, offering the best in medical research & development, advanced technology and optimum clinical services.

Barbara Ann Karmanos Cancer Institute provides health care services for cancer patients. It also provides integrated center of research, patient care and education, dedicated to the prevention, early detection, treatment and eventual eradication of cancer. The company was founded in 1943 and is headquartered in Detroit, MI.

Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC.

University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY.

Cliniconex, Inc. develops software as a service solutions that act as a catalyst to help medical clinics. The company was founded by Anthony Mar in 2009 and is headquartered in Ottawa, Canada.

Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME.

Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.

Osler, Hoskin & Harcourt LLP provides legal services. It offers services in the areas of business law, commercial property, communications and media, trade, construction & infrastructure, corporate finance, and intellectual property. The company was founded in 1862 and is headquartered in Toronto, ON.

Genus Oncology LLC operates as a clinical-stage biopharmaceutical company. It focuses on discovering and developing first-in-class agents against the MUC1-C oncoprotein for the treatment of patients with refractory cancers. The company was founded in 2007 and is headquartered in Chicago, IL.

SOVAR, Inc. provides development and commercialization of new technologies derived from university research and from partnering research centre. It specializes in identifying novel technologies and expertise derived from research activities, develop them and facilitate their transfer into useful and marketable applications. The company was founded in 2000 and is headquartered in St. Foy, Canada.

FOLIA BIOTECH, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on exploiting its proprietary immuno-therapeutic platform to bring to market efficacious therapeutic products that fulfill large unmet needs principally in oncology and certain infectious diseases. The company was founded by Denis Leclerc in 2006 and is headquartered in Quebec, Canada.

Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada.

McKesson Canada Corp. provides healthcare services. It provides pharmaceutical and strategic, automation solutions, and technological solutions. The company was founded in 1905 and is headquartered in Saint-Laurent, Canada.

Business Council of Canada provides program for research and consultation and advocacy of economic and social fabric. The company was founded in 1976 and is headquartered in Ottawa, Canada.

The Canadian Association for Pharmacy Distribution Management (CAPDM) is an organization that represents the healthcare distribution industry in Canada. The private company is based in Woodbridge, Canada. The Canadian company works to save the healthcare system money, safeguard product quality, handle product recalls, and mitigate drug shortage impact. CAPDM simplifies a complex and highly regulated system, driving system costs down and bringing value to the entire supply chain and ultimately patients. The company delivers over 95%% of all retail pharmaceuticals with 99.9+%% accuracy in order fulfillment, next day or sooner deliveries to most pharmacies, and up to 11 deliveries/week to pharmacies. David W. Johnston has been the CEO of the company since 2014.

McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.

Part of Sugar Cane Growers Cooperative of Florida, Refined Sugars, Inc. is a company that manufactures refined sugar. The company is based in Yonkers, NY. Refined Sugars was acquired by Sugar Cane Growers Cooperative of Florida from ONEX Corp. on December 07, 1998.

Part of Procter & Gamble Co., Gillette Canada, Inc. is a Canadian company that manufactures razors. The company is based in Kirkland, Canada.

Food & Consumer Products of Canada is a non-profit organization which represents the companies that manufacture and distribute the vast majority of food, beverage, and consumer goods found on grocery store shelves. It promotes food and product safety, supports health and wellness, collaborates with retailers, and provides environmental services. The organization was founded in 1959 and is headquartered in Mississauga, Canada.

Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA.

Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD.